Beginning Next Week: InsideCounsel will become part of Corporate Counsel. Bringing these two industry-leading websites together will now give you comprehensive coverage of the full spectrum of issues affecting today's General Counsel at companies of all sizes. You will continue to receive expert analysis on key issues including corporate litigation, labor developments, tech initiatives and intellectual property, as well as Women, Influence & Power in Law (WIPL) professional development content. Plus we'll be serving all ALM legal publications from one interconnected platform, powered by, giving you easy access to additional relevant content from other InsideCounsel sister publications.

To prevent a disruption in service, you will be automatically redirected to the new site next week. Thank you for being a valued InsideCounsel reader!


More On

Bayer seeks to block consolidation of failure-to-warn lawsuits over IUDs

Plaintiffs claim that the company’s birth control device perforates the uterus

Bayer AG’s contraceptive products have really been under fire lately. The company is facing more than 10,000 lawsuits over its Yasmin and Yaz birth control pills, some of which it settled earlier this week.

But a popular intrauterine device (IUD) that Bayer manufactures has also been the subject of injury lawsuits, which the company tried to prevent a court from consolidating on Thursday. The suits allege that the Mirena IUD’s label did not adequately warn of the risk that the device could perforate the uterus and migrate elsewhere in the body.

Dawn Chmielewski, a lawyer for many of the plaintiffs, argued that the more than 40 lawsuits filed in different federal courts should be consolidated in front of a single judge for the sake of promoting efficiency. Bayer countered that consolidating the lawsuits would actually slow down the litigation and incentivize plaintiffs to bring more lawsuits.

According to Thomson Reuters, defendants used to be the ones who called for consolidation, overwhelmed by large numbers of cases. In recent years, plaintiffs have increasingly sought consolidation while defendants oppose it. It can sometimes pressure companies into settling, or expand the scope of litigation.


Read more about Bayer on InsideCounsel:

Bayer settles claims of gallbladder injury caused by Yasmin and Yaz contraceptives

Bayer designates $1.5 billion for litigation over Yasmin and Yaz contraceptives

Class action discrimination suit against Bayer can continue

Bayer accused of promoting Yaz birth control for unapproved uses

Join the Conversation

Advertisement. Closing in 15 seconds.